Mei Lietsch, Kee Chan, Jennifer Taylor, Bo Hoon Lee, Emma Ciafaloni, Jennifer M Kwon, Megan A Waldrop, Russell J Butterfield, Geetanjali Rathore, Aravindhan Veerapandiyan, Arya Kapil, Julie A Parsons, Melissa Gibbons, Amy Brower
In the United States and around the world, newborns are screened on a population basis for conditions benefiting from pre-symptomatic diagnosis and treatment. The number of screened conditions continues to expand as novel technologies for screening, diagnosing, treating, and managing disease are discovered. While screening all newborns facilitates early diagnosis and treatment, most screened conditions are treatable but not curable. Patients identified by newborn screening often require lifelong medical management and community support to achieve the best possible outcome...
April 18, 2024: International Journal of Neonatal Screening